Research
The technology developed by Polytheragene originates from research carried out to produce synthetic vectors for the transfer of nucleic acids (DNA and RNA).
Innovation
Polytheragene’s activity lies in the development of polymeric vectors with very low toxicity.
Cationic polymers – PTG1 – containing histidine are effective for the transfection of DNA plasmids. They are very effective for the transfection of HEK293T and CHO cells for the bioproduction of viruses and proteins.
Development
Research and development activities are underway to make them more efficient and more selective. Polymers can be functionalized with fluorescent or spectroscopically active molecules and/or other molecules for targeting.